O discurso do risco na controvérsia dos emagrecedores: uma análise da cobertura de imprensa nos anos de 2011 e 2014
Amaral, Vanessa Melo do; Laguardia, Josué; Cardoso, Janine Miranda.
RECIIS (Online)
; 11(3): 1-19, jul.-set.2017.
Artigo em Português | LILACS | ID: biblio-876444
Documentos relacionados
Anorectic effect of COR659 in a rat model of overeating.
Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells.
Iodination of CART(61-102) peptide: Preserved binding and anorexigenic activity in mice.
Person-centered choice of anti-obesity pharmacotherapy.
Phentermine: A Systematic Review for Plastic and Reconstructive Surgeons.
The unidentified hormonal defense against weight gain.
Pharmacotherapy of obesity: An update.
Three- and six-month efficacy and safety of phentermine in a Mexican obese population.
The Alkylamine Stimulant 1,3-Dimethylamylamine Exhibits Substrate-Like Regulation of Dopamine Transporter Function and Localization.
Análise dos efeitos adversos associados ao uso do anorexígeno sibutramina: revisão sistemática